<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Desipramine for neuropathic pain in adults - Hearn, L - 2014 | Cochrane Library</title> <meta content="Desipramine for neuropathic pain in adults - Hearn, L - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011003.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Desipramine for neuropathic pain in adults - Hearn, L - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011003.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011003.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Desipramine for neuropathic pain in adults" name="citation_title"/> <meta content="Leslie Hearn" name="citation_author"/> <meta content="Churchill Hospital" name="citation_author_institution"/> <meta content="les_hearn@yahoo.co.uk" name="citation_author_email"/> <meta content="R Andrew Moore" name="citation_author"/> <meta content="Sheena Derry" name="citation_author"/> <meta content="Philip J Wiffen" name="citation_author"/> <meta content="Tudor Phillips" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD011003.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/09/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011003.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011003.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011003.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Amitriptyline [therapeutic use]; Analgesics [*therapeutic use]; Antidepressive Agents, Tricyclic [*therapeutic use]; Chronic Pain [*drug therapy]; Clomipramine [therapeutic use]; Desipramine [*therapeutic use]; Diabetic Neuropathies [*drug therapy]; Fluoxetine [therapeutic use]; Neuralgia, Postherpetic [*drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011003.pub2&amp;doi=10.1002/14651858.CD011003.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EBp84H4P";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011003\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011003\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011003.pub2",title:"Desipramine for neuropathic pain in adults",firstPublishedDate:"Sep 23, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011003.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011003.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011003.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011003.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011003.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011003.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011003.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011003.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011003.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011003.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4321 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011003.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-sec1-0006"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/appendices#CD011003-sec1-0011"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Desipramine for neuropathic pain in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#CD011003-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Leslie Hearn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#CD011003-cr-0003">R Andrew Moore</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#CD011003-cr-0004">Sheena Derry</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#CD011003-cr-0005">Philip J Wiffen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information#CD011003-cr-0006">Tudor Phillips</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information/en#CD011003-sec1-0015">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 September 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011003.pub2">https://doi.org/10.1002/14651858.CD011003.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011003-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011003-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011003-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011003-abs-0002">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011003-abs-0001" lang="en"> <section id="CD011003-abs1-0001"> <h3 class="title" id="CD011003-abs1-0001">Background</h3> <p>Antidepressants are widely used to treat chronic neuropathic pain (pain due to nerve damage), usually in doses below those at which they exert antidepressant effects. An earlier review that included all antidepressants for neuropathic pain is being replaced by new reviews of individual drugs examining individual neuropathic pain conditions. </p> <p>Desipramine is a tricyclic antidepressant that is occasionally used for treating neuropathic pain. </p> </section> <section id="CD011003-abs1-0002"> <h3 class="title" id="CD011003-abs1-0002">Objectives</h3> <p>To assess the analgesic efficacy of desipramine for chronic neuropathic pain in adults, and to assess the associated adverse events. </p> </section> <section id="CD011003-abs1-0003"> <h3 class="title" id="CD011003-abs1-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, and EMBASE from inception to 29 April 2014, and the reference lists of retrieved papers and other reviews. We also used our own hand searched database to identify older studies, and two clinical trials databases for ongoing or unpublished studies. </p> </section> <section id="CD011003-abs1-0004"> <h3 class="title" id="CD011003-abs1-0004">Selection criteria</h3> <p>We included randomised, double‐blind studies of at least two weeks duration comparing desipramine with placebo or another active treatment in chronic neuropathic pain. Participants were adults aged 18 years and over. We included only full journal publication articles. </p> </section> <section id="CD011003-abs1-0005"> <h3 class="title" id="CD011003-abs1-0005">Data collection and analysis</h3> <p>Two review authors independently extracted the efficacy and adverse event data, and examined issues of study quality. We performed analysis using three tiers of evidence. First tier evidence was derived from data meeting current best standards and subject to minimal risk of bias (outcome equivalent to substantial pain intensity reduction, intention‐to‐treat analysis without imputation for dropouts, at least 200 participants in the comparison, 8 to 12 weeks duration, parallel design); second tier from data that failed to meet one or more of these criteria and were considered at some risk of bias but with adequate numbers in the comparison; and third tier from data involving small numbers of participants and considered very likely to be biased or that used outcomes of limited clinical utility, or both. </p> </section> <section id="CD011003-abs1-0006"> <h3 class="title" id="CD011003-abs1-0006">Main results</h3> <p>Five studies treated 177 participants with painful diabetic neuropathy (104) or postherpetic neuralgia (73). The mean or median ages in the studies were 55 to 72 years. Four studies used a cross‐over, and one a parallel group design; 145 participants were randomised to receive desipramine 12.5 mg to 250 mg daily, with most taking 100 mg to 150 mg daily following titration. Comparators were placebo in three studies (an 'active placebo' in two studies), fluoxetine, clomipramine (one study each), and amitriptyline (two studies), and treatment was for two to six weeks. All studies had one or more sources of potential major bias. </p> <p>No study provided first or second tier evidence for any outcome. No data were available on the proportion of people with at least 50% or 30% reduction in pain, but data were available from three studies for our other primary outcome of Patient Global Impression of Change, reported as patient evaluation of pain relief that was 'complete' or 'a lot'. No pooling of data was possible, but third tier evidence in individual studies indicated some improvement in pain relief with desipramine compared with placebo, although this was very low quality evidence, derived mainly from group mean data and completer analyses in small, short duration studies where major bias was possible. There were too few participants in comparisons of desipramine with another active treatment to draw any conclusions. </p> <p>All studies reported some information about adverse events, but reporting was inconsistent and fragmented. Participants taking desipramine experienced more adverse events, and a higher rate of withdrawal due to adverse events, than did participants taking placebo (very low quality evidence). </p> </section> <section id="CD011003-abs1-0007"> <h3 class="title" id="CD011003-abs1-0007">Authors' conclusions</h3> <p>This review found little evidence to support the use of desipramine to treat neuropathic pain. There was very low quality evidence of benefit and harm, but this came from studies that were methodologically flawed and potentially subject to major bias. Effective medicines with much greater supportive evidence are available. There may be a role for desipramine in patients who have not obtained pain relief from other treatments. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011003-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011003-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011003-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011003-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011003-abs-0005">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011003-abs-0004" lang="en"> <h3>Desipramine for neuropathic pain in adults</h3> <p>Neuropathic pain is pain coming from damaged nerves. It is different from pain messages carried along healthy nerves from damaged tissue (a fall, cut, or arthritic knee). Neuropathic pain is treated by different medicines than pain from damaged tissue. Medicines like paracetamol or ibuprofen are not usually effective in neuropathic pain, while medicines that are sometimes used to treat depression or epilepsy can be very effective in some people with neuropathic pain. </p> <p>Desipramine is a tricyclic antidepressant from the same class of medicines as amitriptyline, which is widely recommended for treating neuropathic pain. Desipramine may also be useful in these painful conditions. In 2014, we performed searches to look for clinical trials where desipramine was used to treat neuropathic pain. </p> <p>Five small studies, each with 24 to 54 participants, included 177 participants in total with painful diabetic neuropathy or postherpetic neuralgia. Studies were randomised and double‐blind, but all had one or more sources of potential major bias that could lead to overestimation of efficacy. It was not possible to combine information from the different studies, but individually they indicated some benefit from desipramine (usually at a dose between 100 mg and 150 mg daily), compared with placebo, at the expense of increased adverse events. There was not enough information about other comparators to draw any conclusions. </p> <p>There was too little information, which was of inadequate quality, to be sure that desipramine works as a pain medicine in painful diabetic neuropathy or postherpetic neuralgia, and no information about other types of neuropathic pain. Other medicines have been shown to be effective as treatments of first choice. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011003-sec1-0007" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011003-sec1-0007"></div> <h3 class="title" id="CD011003-sec1-0008">Implications for practice</h3> <section id="CD011003-sec1-0008"> <p>This review found little evidence to support the use of desipramine to treat neuropathic pain. There was very low quality evidence of some effect from studies that were methodologically flawed and potentially subject to major bias. There are more effective and safer medicines available. There may be a role for use of desipramine in patients who have not obtained pain relief from other treatments. </p> </section> <h3 class="title" id="CD011003-sec1-0009">Implications for research</h3> <section id="CD011003-sec1-0009"> <p>Larger, better‐designed studies would provide more definitive conclusions on the efficacy of desipramine, but it is unlikely that these will be carried out, given the age of the drug and the alternatives available, or that they could be justified on the evidence available. </p> <p>Reasonable levels of evidence exist for the benefit of other antiepileptic and antidepressant drugs in the treatment of chronic neuropathic pain. There is a need to develop new treatments for neuropathic pain conditions, given that at present we have limited efficacy for a limited number of drugs, and some people remain inadequately treated. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011003-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011003-sec1-0001"></div> <div class="table" id="CD011003-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Desipramine compared with placebo for painful diabetic neuropathy and postherpetic neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia) </p> <p><b>Settings:</b> community </p> <p><b>Intervention:</b> Desipramine 12.5 mg to 250 mg daily </p> <p><b>Comparison:</b> Placebo (or active placebo ‐ benztropine) </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Outcome with comparator (placebo)</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Outcome with intervention</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 50% reduction in pain</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 30% reduction in pain</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion below 30/100 mm on VAS</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patient Global Impression of Change very much improved (PGPR "complete" or "a lot")</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3.8 % and 8.3% (3 events)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>17% and 30%</p> <p>(12 events)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 participants, 2 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 2 studies with short duration, cross‐over design, different painful neuropathy condition </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patient Global Impression of Change much or very much improved (PGPR "complete", "a lot", or "moderate") </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>7.7% and 8.3%</p> <p>(4 events)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>46% in both studies</p> <p>(23 events)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 participants, 2 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 2 studies with short duration, cross‐over design, different painful neuropathy condition </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse event withdrawals</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0% to 12%</p> <p>(4 events)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0% to 19%</p> <p>(10 events)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 participants, 3 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 3 studies with short duration, cross‐over design</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177 participants, 5 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 5 studies of short duration (placebo‐ and active‐controlled)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Death</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177 participants, 5 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 5 studies of short duration (placebo‐ and active‐controlled)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI: confidence interval; PGPR: Patient global evaluation of pain relief; RR: risk ratio; VAS: visual analogue scale; n/a: not applicable </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011003-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011003-sec1-0002"></div> <p>This review is based on a template for reviews of drugs used to relieve neuropathic pain. The aim is for all reviews to use the same methods, based on new criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD011003-bbs2-0039" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>) (<a href="./appendices#CD011003-sec2-0016">Appendix 1</a>). </p> <p>Desipramine is a tricyclic antidepressant (TCA) that is sometimes used to treat chronic neuropathic pain (pain due to nerve damage or changes in the central nervous system (CNS)). While its use is not specifically recommended, it is listed alongside other tricyclic antidepressants in some treatment guidelines, although this is an unlicensed indication (<a href="./references#CD011003-bbs2-0009" title="AttalN , CruccuG , BaronR , HaanpääM , HanssonP , JensenTS , et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x] ">Attal 2010</a>; <a href="./references#CD011003-bbs2-0016" title="DworkinRH , O'ConnorAB , AudetteJ , BaronR , GourlayGK , HaanpääML , et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings2010;85(3 Suppl):S3‐14. [DOI: 10.4065/mcp.2009.0649] ">Dworkin 2010</a>; <a href="./references#CD011003-bbs2-0018" title="FinnerupNB , SindrupSH , JensenTS . The evidence for pharmacological treatment of neuropathic pain. Pain2010;150(3):573‐81. [DOI: 10.1016/j.pain.2010.06.019] ">Finnerup 2010</a>; <a href="./references#CD011003-bbs2-0051" title="MoulinDE , ClarkAJ , GilronI , WareMA , WatsonCP , SessleBJ , et al. Pharmacological management of chronic neuropathic pain ‐ consensus statement and guidelines from the Canadian Pain Society. Pain Research and Management2007;12(1):13‐21. ">Moulin 2007</a>). It is an active metabolite of imipramine, the subject of another Cochrane review (<a href="./references#CD011003-bbs2-0022" title="HearnL , WiffenPJ , MooreRA , DerryS . Imipramine for neuropathic pain in adults. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD010769.pub2] ">Hearn 2014</a>). </p> <section id="CD011003-sec2-0001"> <h3 class="title" id="CD011003-sec2-0001">Description of the condition</h3> <p>The 2011 International Association for the Study of Pain (IASP) definition of neuropathic pain is "pain caused by a lesion or disease of the somatosensory system" (<a href="./references#CD011003-bbs2-0025" title="JensenTS , BaronR , HaanpääM , KalsoE , LoeserJD , RiceAS , et al. A new definition of neuropathic pain. Pain2011; Vol. 152, issue 10:2204‐5. [DOI: 10.1016/j.pain.2011.06.017] ">Jensen 2011</a>), based on an earlier consensus meeting (<a href="./references#CD011003-bbs2-0066" title="TreedeRD , JensenTS , CampbellJN , CruccuG , DostrovskyJO , GriffinJW , et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology2008;70(18):1630‐5. [DOI: 10.1212/01.wnl.0000282763.29778.59] ">Treede 2008</a>). Neuropathic pain may be caused by nerve damage, but is often followed by changes in the CNS (<a href="./references#CD011003-bbs2-0035" title="MoissetX , BouhassiraD . Brain imaging of neuropathic pain. NeuroImage2007;37 Suppl 1:S80‐8. [DOI: 10.1016/j.neuroimage.2007.03.054] ">Moisset 2007</a>). It is complex (<a href="./references#CD011003-bbs2-0008" title="ApkarianAV , HashmiJA , BalikiMN . Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain2011;152(3 Suppl):S49‐64. [DOI: 10.1016/j.pain.2010.11.010] ">Apkarian 2011</a>; <a href="./references#CD011003-bbs2-0065" title="TraceyI . Can neuroimaging studies identify pain endophenotypes in humans?. Nature Reviews Neurology2011;7(3):173‐81. [DOI: 10.1038/nrneurol.2011.4] ">Tracey 2011</a>), and neuropathic pain features can be found in patients with joint pain (<a href="./references#CD011003-bbs2-0059" title="SoniA , BatraR , GwilymS , SpectorT , HartD , ArdenN , et al. Neuropathic features of joint pain: A community‐based study. Arthritis &amp; Rheumatism2013;April 1:Epub ahead of print. [DOI: 10.1002/art.37962] ">Soni 2013</a>). Many people with neuropathic pain conditions are significantly disabled with moderate or severe pain for many years. </p> <p>Chronic painful conditions comprise five of the 11 top‐ranking conditions for years lived with disability in 2010 (<a href="./references#CD011003-bbs2-0067" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990‐2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380(9859):2163‐96. [DOI: 10.1016/S0140‐6736(12)61729‐2] ">Vos 2012</a>), and are responsible for considerable loss of quality of life, employment, and increased health costs (<a href="./references#CD011003-bbs2-0049" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. [DOI: 10.1111/papr.12050] ">Moore 2014a</a>). </p> <p>In primary care in the UK, the incidences, per 100,000 person‐years observation, have been reported as 28 (95% confidence interval (CI) 27 to 30) for postherpetic neuralgia, 27 (95% CI 26 to 29) for trigeminal neuralgia, 0.8 (95% CI 0.6 to 1.1) for phantom limb pain, and 21 (95% CI 20 to 22) for painful diabetic neuropathy (<a href="./references#CD011003-bbs2-0020" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). The incidence of postherpetic neuralgia in the UK appears to be increasing (<a href="./references#CD011003-bbs2-0021" title="HallGC , MorantSV , CarrollD , GabrielZL , McQuayHJ . An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population. BMC Family Practice2013;14:28. [DOI: 10.1186/1471‐2296‐14‐28] ">Hall 2013</a>). Estimates vary between studies, often because of small numbers of cases. The incidence of trigeminal neuralgia has been estimated at 4 in 100,000 per year (<a href="./references#CD011003-bbs2-0026" title="KatusicS , WilliamsDB , BeardCM , BergstralhEJ , KurlandLT . Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945‐1984. Neuroepidemiology1991;10:276‐81. ">Katusic 1991</a>; <a href="./references#CD011003-bbs2-0057" title="RappaportZH , DevorM . Trigeminal neuralgia: the role of self‐sustaining discharge in the trigeminal ganglion. Pain1994;56:127‐38. [DOI: 10.1016/0304‐3959(94)90086‐8] ">Rappaport 1994</a>), while more recently, a study of facial pain in the Netherlands found incidences per 100,000‐person years of 12.6 for trigeminal neuralgia and 3.9 for postherpetic neuralgia (<a href="./references#CD011003-bbs2-0028" title="KoopmanJS , DielemanJP , HuygenFJ , deMosM , MartinCG , SturkenboomMC . Incidence of facial pain in the general population. Pain2009;147(1‐3):122‐7. [DOI: 10.1016/j.pain.2009.08.023] ">Koopman 2009</a>). A systematic review of chronic pain demonstrated that some neuropathic pain conditions, such as painful diabetic neuropathy, can be more common, with prevalence rates up to 400 per 100,000 person‐years (<a href="./references#CD011003-bbs2-0033" title="McQuayHJ , SmithLA , MooreRA . Chronic Pain. In: StevensA , RafteryJ , MantJ , SimpsonS editor(s). Health Care Needs Assessment. 3rd Edition. Oxford: Radcliffe Publishing, 2007. [ISBN: 978‐1‐84619‐063‐6] ">McQuay 2007</a>), illustrating how common the condition is, as well as its chronicity. The prevalence of neuropathic pain was reported as being 3.3% in Austria (<a href="./references#CD011003-bbs2-0019" title="GustorffB , DornerT , LikarR , GrisoldW , LawrenceK , SchwarzF , et al. Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica2008;52(1):132‐6. [DOI: 10.1111/j.1399‐6576.2007.01486.x] ">Gustorff 2008</a>), 6.9% in France (<a href="./references#CD011003-bbs2-0011" title="BouhassiraD , Lantéri‐MinetM , AttalN , LaurentB , TouboulC . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain2008;136(3):380‐7. [DOI: 10.1016/j.pain.2007.08.013] ">Bouhassira 2008</a>), as high as 8% in the UK (<a href="./references#CD011003-bbs2-0064" title="TorranceN , SmithBH , BennettMI , LeeAJ . The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. Journal of Pain2006;7(4):281‐9. [DOI: 10.1016/j.jpain.2005.11.008] ">Torrance 2006</a>), and about 7% in a systematic review of studies published since 2000 (<a href="./references#CD011003-bbs2-0049" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. [DOI: 10.1111/papr.12050] ">Moore 2014a</a>). The incidence of some forms of neuropathic pain, such as diabetic neuropathy and postsurgical chronic pain (which is often neuropathic in origin), is increasing (<a href="./references#CD011003-bbs2-0020" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). </p> <p>Neuropathic pain is known to be difficult to treat effectively, with only a minority of individuals experiencing a clinically relevant benefit from any one intervention. A multidisciplinary approach is now advocated, with pharmacological interventions being combined with physical or cognitive interventions, or both. Conventional analgesics are usually not effective. Some patients may derive some benefit from a topical lidocaine patch or low concentration topical capsaicin, though evidence about benefits is uncertain (<a href="./references#CD011003-bbs2-0012" title="DerryS , MooreRA . Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD010111] ">Derry 2012</a>; <a href="./references#CD011003-bbs2-0014" title="DerryS , MooreRA . Topical lidocaine for neuropathic pain in adults. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD010958] ">Derry 2014</a>). High‐concentration topical capsaicin may benefit some patients with postherpetic neuralgia (<a href="./references#CD011003-bbs2-0013" title="DerryS , Sven‐RiceA , ColeP , TanT , MooreRA . Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD007393.pub3] ">Derry 2013</a>). Treatment is more usually by so‐called unconventional analgesics such as antidepressants like duloxetine and amitriptyline (<a href="./references#CD011003-bbs2-0031" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] ">Lunn 2014</a>; <a href="./references#CD011003-bbs2-0045" title="MooreRA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD008242.pub2] ">Moore 2012a</a>; <a href="./references#CD011003-bbs2-0063" title="SultanA , GaskellH , DerryS , MooreRA . Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology2008;8:29. [DOI: 10.1186/1471‐2377‐8‐29] ">Sultan 2008</a>), or antiepileptics like gabapentin or pregabalin (<a href="./references#CD011003-bbs2-0038" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>; <a href="./references#CD011003-bbs2-0050" title="MooreRA , WiffenPJ , DerryS , ToelleT , RiceAS . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD007938.pub3] ">Moore 2014b</a>). An overview of treatment guidelines shows general similarities based on the evidence available, but guidelines are not always consistent with one another (<a href="./references#CD011003-bbs2-0055" title="O'ConnorAB , DworkinRH . Treatment of neuropathic pain: an overview of recent guidelines. American Journal of Medicine2009;122(10 Suppl):S22‐32. [DOI: 10.1016/j.amjmed.2009.04.007] ">O'Connor 2009</a>). The proportion of patients who achieve worthwhile pain relief (typically at least 50% pain intensity reduction (<a href="./references#CD011003-bbs2-0047" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple, universal outcome. Anaesthesia2013;68(4):400‐12. [DOI: 10.1111/anae.12148] ">Moore 2013a</a>)) is small, generally 10% to 25% more than with placebo, with numbers needed to treat to benefit (NNTs) usually between 4 and 10 (<a href="./references#CD011003-bbs2-0048" title="MooreA , DerryS , EcclestonC , KalsoE . Expect analgesic failure; pursue analgesic success. BMJ2013;346:f2690. [DOI: 10.1136/bmj.f2690] ">Moore 2013b</a>). </p> </section> <section id="CD011003-sec2-0002"> <h3 class="title" id="CD011003-sec2-0002">Description of the intervention</h3> <p>Desipramine is a tricyclic antidepressant, and is an active metabolite of imipramine, which is the subject of a separate review (<a href="./references#CD011003-bbs2-0022" title="HearnL , WiffenPJ , MooreRA , DerryS . Imipramine for neuropathic pain in adults. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD010769.pub2] ">Hearn 2014</a>). While these medicines are still used to treat depressive illness, they have also been used to treat neuropathic pain, although they are not licensed for use in this context in the UK or USA. </p> <p>Desipramine is available as tablets (10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg). For treating neuropathic pain, typical starting dosages are between 10 mg and 25 mg daily, usually taken at night, increasing to 150 mg daily if necessary. Common adverse events associated with its use include dry mouth, constipation, weight gain, blurred vision, and orthostatic hypotension. It is less sedating than amitriptyline. </p> </section> <section id="CD011003-sec2-0003"> <h3 class="title" id="CD011003-sec2-0003">How the intervention might work</h3> <p>Desipramine is a very strong reuptake inhibitor of norepinephrine, and to a lesser extent, serotonin. It is also a metabolite of imipramine. Its mechanism of action in the treatment of neuropathic pain remains uncertain, but it is thought that norepinephrine reuptake inhibition causes activation of descending pathways in the spinal cord, which then block ascending signals to the brain. Tricyclic antidepressants are also known to inhibit sodium channels in nerve membranes, with an efficacy comparable to conventional local anaesthetics (<a href="./references#CD011003-bbs2-0030" title="LenkeyN , KarolyR , KissJP , SzaszBK , ViziES , MikeA . The mechanism of activity‐dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine. Molecular Pharmacology2006;70(6):2052‐63. [DOI: 10.1124/mol.106.026419] ">Lenkey 2006</a>; <a href="./references#CD011003-bbs2-0062" title="SudohY , CahoonEE , GernerP , WangGK . Tricyclic antidepressants as long‐acting local anesthetics. Pain2003;103(1‐2):49‐55. [DOI: 10.1016/S0304‐3959(02)00375‐5] ">Sudoh 2003</a>). This would predict a rapid onset of pain relief. TCAs are known to block sodium channels, binding at the local anaesthetic site at plasma levels found with therapeutically relevant doses. </p> <p>That the mechanism differs from that in treating depression is confirmed by the observation that analgesia with antidepressants is often achieved at a lower dosage than for the onset of any antidepressant effect, and more promptly. In addition, there is no correlation between the effects of antidepressants on mood and pain, and antidepressants produce analgesia in patients with and without depression (<a href="./references#CD011003-bbs2-0056" title="OnghenaP , VanHoudenhoveB . Antidepressant‐induced analgesia in chronic non‐malignant pain: a meta‐analysis of 39 placebo‐controlled studies. Pain1992;49:205‐20. ">Onghena 1992</a>). </p> </section> <section id="CD011003-sec2-0004"> <h3 class="title" id="CD011003-sec2-0004">Why it is important to do this review</h3> <p>The earlier review of antidepressants for neuropathic pain is being updated with separate reviews for individual drugs due to the larger amount of data now available for some of them (<a href="./references#CD011003-bbs2-0068" title="SaartoT , WiffenPJ . Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2] ">Saarto 2007</a>). The individual reviews (including amitriptyline (<a href="./references#CD011003-bbs2-0045" title="MooreRA , DerryS , AldingtonD , ColeP , WiffenPJ . Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD008242.pub2] ">Moore 2012a</a>), imipramine (<a href="./references#CD011003-bbs2-0022" title="HearnL , WiffenPJ , MooreRA , DerryS . Imipramine for neuropathic pain in adults. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD010769.pub2] ">Hearn 2014</a>), and duloxetine (<a href="./references#CD011003-bbs2-0031" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] ">Lunn 2014</a>)) will be included in an overview review of antidepressant drugs for neuropathic pain. </p> <p>The standards used to assess evidence in chronic pain trials have changed substantially, with particular attention being paid to trial duration, withdrawals, and statistical imputation following withdrawal, all of which can substantially alter estimates of efficacy (<a href="./appendices#CD011003-sec2-0016">Appendix 1</a>). The most important change is the move from using average pain scores, or average change in pain scores, to the number of patients who have a large decrease in pain (by at least 50%) and who continue their treatment, ideally in trials of 8 to 12 weeks or longer. Pain intensity reduction of 50% or more has been shown to correlate with improvements in comorbid symptoms, function, and quality of life. These standards are set out in the reference guide for pain studies (<a href="./references#CD011003-bbs2-0010" title="CochranePain , Palliative and Supportive Care Group. PaPaS Author and Referee Guidance. http://papas.cochrane.org/sites/papas.cochrane.org/files/uploads/L%20‐%20PaPaSAuthor%26RefereeGuidance.pdf (accessed 22 January 2013). ">AUREF 2012</a>). </p> <p>This Cochrane systematic review assesses evidence in ways that make both statistical and clinical sense, and uses developing criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD011003-bbs2-0039" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>). Trials included and analysed meet a minimum of reporting quality (blinding, randomisation), validity (duration, dose and timing, diagnosis, outcomes) and size (ideally at least 500 participants in a comparison in which the NNT is four or above (<a href="./references#CD011003-bbs2-0036" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. [DOI: 10.1016/S0304‐3959(98)00140‐7] ">Moore 1998</a>)). This does set high standards and marks a departure from how reviews have been done previously. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011003-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011003-sec1-0003"></div> <p>To assess the analgesic efficacy of desipramine for chronic neuropathic pain in adults, and to evaluate adverse events reported in the studies. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011003-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011003-sec1-0004"></div> <section id="CD011003-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011003-sec3-0001"> <h4 class="title">Types of studies</h4> <p>We included studies if they were randomised controlled trials (RCTs) with double‐blind assessment of participant outcomes following two weeks of treatment or longer, although the emphasis of the review was on studies of eight weeks or longer. We required full journal publication, with the exception of online clinical trial results summaries of otherwise unpublished clinical trials and abstracts with sufficient data for analysis. We did not include short abstracts (usually meeting reports). We excluded studies that were non‐randomised, studies of experimental pain, case reports, and clinical observations. </p> </section> <section id="CD011003-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Participants were aged 18 years and above and could have one or more of a wide range of chronic neuropathic pain conditions including (but not limited to): </p> <p> <ul id="CD011003-lst1-0001"> <li> <p>cancer‐related neuropathy;</p> </li> <li> <p>complex regional pain syndrome (CRPS) Type II;</p> </li> <li> <p>human immunodeficiency virus (HIV) neuropathy;</p> </li> <li> <p>painful diabetic neuropathy;</p> </li> <li> <p>phantom limb pain;</p> </li> <li> <p>postherpetic neuralgia;</p> </li> <li> <p>postoperative or traumatic neuropathic pain;</p> </li> <li> <p>spinal cord injury;</p> </li> <li> <p>trigeminal neuralgia;</p> </li> </ul> </p> <p>and</p> <p> <ul id="CD011003-lst1-0002"> <li> <p>CRPS Type I.</p> </li> </ul> </p> <p>We would include studies of participants with more than one type of neuropathic pain; in such cases we would analyse results according to the primary condition. Migraine and headache studies were excluded. </p> </section> <section id="CD011003-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>Oral desipramine at any dose, administered for the relief of neuropathic pain and compared to placebo or any active comparator. </p> </section> <section id="CD011003-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <p>Studies used a variety of outcome measures, with the majority using subjective scales (numerical rating scale (NRS) or visual analogue scale (VAS)) for pain intensity or pain relief, or both. We were particularly interested in the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) definitions for moderate and substantial benefit in chronic pain studies (<a href="./references#CD011003-bbs2-0015" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. [DOI: 10.1016/j.jpain.2007.09.005] ">Dworkin 2008</a>). These are defined as at least 30% pain relief over baseline (moderate), at least 50% pain relief over baseline (substantial), much or very much improved on the Patient Global Impression of Change (PGIC) (moderate), and very much improved on the PGIC (substantial). These outcomes concentrate on dichotomous outcomes in circumstances where pain responses do not follow a normal (Gaussian) distribution. People with chronic pain desire high levels of pain relief, ideally more than 50%, and with pain not worse than mild (<a href="./references#CD011003-bbs2-0054" title="O'BrienEM , StaudRM , HassingerAD , McCullochRC , CraggsJG , AtchisonJW , et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Medicine2010;11(1):6‐15. [DOI: 10.1111/j.1526‐4637.2009.00685.x] ">O'Brien 2010</a>). </p> <p>We have included a 'Summary of findings' table as set out in the author guide (<a href="./references#CD011003-bbs2-0010" title="CochranePain , Palliative and Supportive Care Group. PaPaS Author and Referee Guidance. http://papas.cochrane.org/sites/papas.cochrane.org/files/uploads/L%20‐%20PaPaSAuthor%26RefereeGuidance.pdf (accessed 22 January 2013). ">AUREF 2012</a>), which includes outcomes of at least 50% and at least 30% pain intensity reduction, PGIC, adverse event withdrawals, serious adverse events and death (<a href="./full#CD011003-tbl-0001">summary of findings Table for the main comparison</a>). </p> <section id="CD011003-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011003-lst1-0003"> <li> <p>Patient‐reported pain relief of 30% or greater</p> </li> <li> <p>Patient‐reported pain relief of 50% or greater</p> </li> <li> <p>PGIC much or very much improved</p> </li> <li> <p>PGIC very much improved</p> </li> </ol> </p> </section> <section id="CD011003-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011003-lst1-0004"> <li> <p>Any pain‐related outcome indicating some improvement</p> </li> <li> <p>Withdrawals due to lack of efficacy</p> </li> <li> <p>Participants experiencing any adverse event</p> </li> <li> <p>Participants experiencing any serious adverse event. Serious adverse events typically include any untoward medical occurrence or effect that at any dose results in death, is life‐threatening, requires hospitalisation or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, is a congenital anomaly or birth defect, is an ‘important medical event’ that may jeopardise the patient, or may require an intervention to prevent one of the above characteristics or consequences </p> </li> <li> <p>Withdrawals due to adverse events</p> </li> <li> <p>Specific adverse events, particularly somnolence and dizziness</p> </li> </ol> </p> <p>These outcomes were not eligibility criteria for this review, but outcomes of interest within the included studies. </p> </section> </section> </section> <section id="CD011003-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011003-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases:</p> <p> <ul id="CD011003-lst1-0005"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2014, Issue 4 of 12); </p> </li> <li> <p>MEDLINE (via Ovid) (1946 to 29 April 2014);</p> </li> <li> <p>EMBASE (via Ovid) (1974 to 29 April 2014).</p> </li> </ul> </p> <p>Search strategies for CENTRAL, MEDLINE, and EMBASE are in <a href="./appendices#CD011003-sec2-0017">Appendix 2</a>, <a href="./appendices#CD011003-sec2-0018">Appendix 3</a>, and <a href="./appendices#CD011003-sec2-0019">Appendix 4</a>. There were no language restrictions. </p> </section> <section id="CD011003-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>We reviewed the bibliographies of any randomised trials identified and review articles, and searched clinical trial databases (ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>)) to identify additional published or unpublished data. We did not contact investigators or study sponsors because of the age of the studies identified and because this is not an area of active research. </p> </section> </section> <section id="CD011003-sec2-0007"> <h3 class="title" id="CD011003-sec2-0007">Data collection and analysis</h3> <p>The intention was to perform separate analyses according to particular neuropathic pain conditions. Analyses combining different neuropathic pain conditions would be done for exploratory purposes only. </p> <section id="CD011003-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>We determined eligibility by reading the abstract of each study identified by the search. We eliminated studies that clearly did not satisfy the inclusion criteria, and we obtained full copies of the remaining studies; decisions were made by two review authors. Two review authors then read these studies independently and reached agreement by discussion. We did not anonymise the studies in any way before assessment. A Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow chart shows the selection process (<a href="./references#CD011003-bbs2-0034" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , the PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. ">Moher 2009</a>). </p> </section> <section id="CD011003-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data using a standard form and checked for agreement before entry into the Cochrane Collaboration's statistical software (<a href="./references#CD011003-bbs2-0058" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013. ">Review Manager 2013</a>) or any other analysis tool. We included information about the pain condition and number of participants treated, drug and dosing regimen, study design (placebo or active control), study duration and follow‐up, analgesic outcome measures and results, withdrawals and adverse events (participants experiencing any adverse event, or serious adverse event). </p> </section> <section id="CD011003-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Oxford Quality Score as the basis for inclusion (<a href="./references#CD011003-bbs2-0024" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. [DOI: doi.org/10.1016/0197‐2456(95)00134‐4] ">Jadad 1996</a>), limiting inclusion to studies that were randomised and double‐blind as a minimum. </p> <p>Two authors independently assessed risk of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011003-bbs2-0023" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration. ">Higgins 2011</a>) and adapted from those used by the Cochrane Pregnancy and Childbirth Group, with any disagreements resolved by discussion. </p> <p>We assessed the following for each study.</p> <p> <ol id="CD011003-lst1-0006"> <li> <p>Random sequence generation (checking for possible selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, for example random number table; computer random number generator); unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (for example, odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for possible selection bias). The method used to conceal allocation to interventions prior to assignment determines whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. We assessed the methods as: low risk of bias (for example, telephone or central randomisation; consecutively numbered sealed opaque envelopes); unclear risk of bias (method not clearly stated). We excluded studies that did not conceal allocation (for example, open list). </p> </li> <li> <p>Blinding of outcome assessment (checking for possible detection bias). We assessed the methods used to blind study participants and outcome assessors from knowledge of which intervention a participant received. We assessed the methods as: low risk of bias (study stated that it was blinded and described the method used to achieve blinding, for example, identical tablets; matched in appearance and smell); unclear risk of bias (study stated that it was blinded but did not provide an adequate description of how it was achieved). We excluded studies that were not double‐blind. </p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias due to the amount, nature, and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk (&lt; 10% of participants did not complete the study or used ‘baseline observation carried forward' (BOCF) analysis, or both); unclear risk of bias (used 'last observation carried forward' (LOCF) analysis); high risk of bias (used 'completer' analysis). </p> </li> <li> <p>Size of study (checking for possible biases confounded by small size). We assessed studies as being at low risk of bias (≥ 200 participants per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm); high risk of bias (&lt; 50 participants per treatment arm). </p> </li> </ol> </p> </section> <section id="CD011003-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>We planned to calculate numbers needed to treat (NNTs) as the reciprocal of the absolute risk reduction (ARR) (<a href="./references#CD011003-bbs2-0032" title="McQuayH , MooreR . An evidence‐based resource for pain relief. Oxford: Oxford University Press, 1998. ">McQuay 1998</a>). For unwanted effects, the NNT becomes the number needed to treat to harm (NNH) and is calculated in the same manner. We planned to use dichotomous data to calculate risk ratio (RR) with 95% CI using a fixed‐effect model unless significant statistical heterogeneity was found (<a href="#CD011003-sec3-0013">Assessment of heterogeneity</a>). Continuous data were not used in the analyses. </p> </section> <section id="CD011003-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <p>The control treatment arm would be split between active treatment arms in a single study if the active treatment arms were not combined for analysis. </p> <p>For cross‐over studies we planned to use first period data only wherever possible. Where this was not reported we analysed the data as if the treatment periods were parallel, drawing attention to the potential bias this may introduce, and interpreting the results accordingly. </p> </section> <section id="CD011003-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>Where possible we have used intention‐to‐treat (ITT) analysis where the ITT population consists of participants who were randomised, took at least one dose of the assigned study medication, and provided at least one post‐baseline assessment. Missing participants were assigned zero improvement. Where this was not possible we have used the results as reported, but drawn attention to the potential bias this may introduce. These data were not used in any analyses. </p> </section> <section id="CD011003-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to deal with clinical heterogeneity by combining studies that examined similar conditions. We would have assessed statistical heterogeneity visually (<a href="./references#CD011003-bbs2-0029" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107:224‐33. ">L'Abbé 1987</a>), and with the use of the I<sup>2</sup> statistic. </p> </section> <section id="CD011003-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>The aim of this review was to use dichotomous data of known utility (<a href="./references#CD011003-bbs2-0041" title="MooreRA , StraubeS , PaineJ , PhillipsCJ , DerryS , McQuayHJ . Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain2010;149(2):360‐4. [DOI: 10.1016/j.pain.2010.02.039] ">Moore 2010c</a>). The review did not depend on what authors of the original studies chose to report or not, though clearly difficulties arose in studies failing to report any dichotomous results. We have extracted and reported continuous data, which probably poorly reflect efficacy and utility, where useful, for illustrative purposes only. </p> <p>We planned to assess publication bias using a method designed to detect the amount of unpublished data with a null effect required to make any result clinically irrelevant (usually taken to mean an NNT of 10 or higher) (<a href="./references#CD011003-bbs2-0037" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: MooreRA , KalsoE , McQuayHJ editor(s). Systematic Reviews in Pain Research: Methodology Refined. 1st Edition. Seattle: IASP Press, 2008:15‐24. [ISBN: 978‐0931092695] ">Moore 2008</a>). </p> </section> <section id="CD011003-sec3-0015"> <h4 class="title">Data synthesis</h4> <p>We planned to use a fixed‐effect model for meta‐analysis or use a random‐effects model for meta‐analysis if there was significant clinical heterogeneity and it was considered appropriate to combine studies. </p> <p>We analysed data for each painful condition in three tiers, according to outcome and freedom from known sources of bias. </p> <p> <ul id="CD011003-lst1-0007"> <li> <p>The first tier uses data meeting current best standards, where studies report the outcome of at least 50% pain intensity reduction over baseline (or its equivalent), without the use of LOCF or other imputation method for dropouts, report an ITT analysis, last eight or more weeks, have a parallel‐group design, and have at least 200 participants (preferably at least 400) in the comparison (<a href="./references#CD011003-bbs2-0039" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [DOI: 10.1016/j.pain.2010.05.011] '>Moore 2010a</a>; <a href="./references#CD011003-bbs2-0046" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. ">Moore 2012b</a>). These top tier results are reported first. </p> </li> <li> <p>The second tier uses data from at least 200 participants but where one or more of the above conditions is not met (for example reporting at least 30% pain intensity reduction, using LOCF or a completer analysis, or lasting four to eight weeks). </p> </li> <li> <p>The third tier of evidence relates to data from fewer than 200 participants, or where there are expected to be significant problems because, for example, of very short duration studies of less than four weeks, where there is major heterogeneity between studies, or where there are shortcomings in allocation concealment, attrition, or incomplete outcome data. For this third tier of evidence, no data synthesis is reasonable, and may be misleading, but an indication of beneficial effects might be possible. </p> </li> </ul> </p> </section> <section id="CD011003-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned all analyses to be according to individual painful conditions, because placebo response rates with the same outcome can vary between conditions, as can the drug‐specific effects (<a href="./references#CD011003-bbs2-0038" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>). If there had been sufficient data we would have carried out subgroup analysis for dose of desipramine and duration of study. </p> </section> <section id="CD011003-sec3-0017"> <h4 class="title">Sensitivity analysis</h4> <p>If there had been sufficient data we would have examined details of dose escalation schedules to investigate if this could provide some basis for a sensitivity analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011003-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011003-sec1-0005"></div> <section id="CD011003-sec2-0008"> <h3 class="title">Description of studies</h3> <section id="CD011003-sec3-0018"> <h4 class="title">Results of the search</h4> <p>Searches of bibliographic databases found 33 titles in CENTRAL, 160 in MEDLINE, and 140 in EMBASE, which we examined for inclusion. After screening titles and abstracts, we obtained full copies and examined seven reports in detail. We included five studies and excluded two (<a href="#CD011003-fig-0001">Figure 1</a>). Searches of trial databases and study or review reference lists did not identify any additional studies. </p> <div class="figure" id="CD011003-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011003-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011003-sec3-0019"> <h4 class="title">Included studies</h4> <p>Five studies treated 177 participants, of whom 145 were randomised to desipramine (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>); in the cross‐over studies, however, it was not clear that all randomised participants received all treatments, and most studies did not report results for all randomised participants (that is, completer analyses reported). In four studies, there was a desipramine dose‐finding phase (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>): in the first of these, 3 out of 32 participants withdrew because of adverse effects. Participants took oral desipramine for between two and six weeks. Daily doses were between 12.5 mg and 250 mg daily (mostly 100 mg to 200 mg). The licensed maximum dose is 300 mg. In one study, poor metabolisers were treated with lower doses (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). </p> <p>Study participants were aged between 20 and 84 years (study means or medians from 55 to 72 years), with an approximately five to four ratio of men to women (94 men; 76 women; 7 not stated (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>)). Participants had experienced pain associated with postherpetic neuralgia (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>) (73 participants) or diabetic neuropathy (<a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>) (104 participants) for at least three months. Common grounds for exclusion from studies were severe depression, severe pain of other cause, and medical contra‐indication. </p> <p>In three studies, desipramine was compared to placebo (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>) or active placebo (benztropine) (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>). The active placebo was chosen to mimic dry mouth, which is associated with TCAs, and help maintain blinding. </p> <p>In three studies, other analgesics were compared to desipramine: clomipramine (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>); amitriptyline (<a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>); fluoxetine (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>). </p> <p>One study used a parallel‐group design (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>), while the other four used a cross‐over design (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). One study had washout periods between cross‐over periods (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). </p> <p>Stable medication for diabetes was maintained.</p> </section> <section id="CD011003-sec3-0020"> <h4 class="title">Excluded studies</h4> <p>We excluded two studies after reading the full papers. <a href="./references#CD011003-bbs2-0006" title="CoquozD , PorchetHC , DayerP . [Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide] [Effet analgesique central d'antidepresseurs a mode d'action distinct: desipramine, fluvoxamine et moclobemide]. Schweizerische Medizinische Wochenschrift1991;121(49):1843‐5. ">Coquoz 1991</a> used participants who were healthy volunteers, while <a href="./references#CD011003-bbs2-0007" title="RajaSN , HaythornthwaiteJA , PappagalloM , ClarkMR , TravisonTG , SabeenS , et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo‐controlled trial. Neurology2002;59(7):1015‐21. ">Raja 2002</a> randomised participants to drug classes, not to individual drugs, and results for individual drugs were not reported separately. </p> </section> </section> <section id="CD011003-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <p>Comments on potential biases in individual studies are reported in the risk of bias section of the <a href="./references#CD011003-sec2-0024" title="">Characteristics of included studies</a> table. The findings are displayed in <a href="#CD011003-fig-0002">Figure 2</a> and <a href="#CD011003-fig-0003">Figure 3</a>; no sensitivity analysis was undertaken. The greatest risk of bias came from small study size. </p> <div class="figure" id="CD011003-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011003-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011003-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011003-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011003-sec3-0021"> <h4 class="title">Allocation</h4> <p>All studies were randomised. No studies adequately described how allocation to treatment groups was concealed. </p> </section> <section id="CD011003-sec3-0022"> <h4 class="title">Blinding</h4> <p>All studies were double blind. Only one study (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>) adequately described the methods used to ensure that participants and interacting investigators were unable to differentiate between active and control groups; another referred to use of placebo capsules to maintain the same dosing regime (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>). </p> </section> <section id="CD011003-sec3-0023"> <h4 class="title">Incomplete outcome data</h4> <p>All four cross‐over studies (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>) performed efficacy analyses only on those participants who completed all treatment phases of the study (completer analyses), and did not report results for the first phase only. The parallel group study performed an intention‐to‐treat (ITT) analysis (imputation not reported) (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>). </p> <p>Proportions of withdrawals with desipramine varied: 5/26 (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>); 2/24 (<a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>); 7/54 (<a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>); 2/15 (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>); 3/26 (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). Therefore, some 13% of participants randomised to desipramine dropped out. </p> <p>Missing participants can sometimes be added back in (analysed as non‐responders) for dichotomous outcomes, but this is not possible when mean data are reported. </p> </section> <section id="CD011003-sec3-0024"> <h4 class="title">Selective reporting</h4> <p>All studies reported the outcomes specified in their methods but these were usually not our preferred (primary) outcomes. Pain was not reported separately in <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>. </p> </section> <section id="CD011003-sec3-0025"> <h4 class="title">Other potential sources of bias</h4> <p>None of the studies randomised sufficient numbers of participants to minimise the bias associated with small studies (<a href="./references#CD011003-bbs2-0053" title="NüeschE , TrelleS , ReichenbachS , RutjesAW , TschannenB , AltmanDG , et al. Small study effects in meta‐analyses of osteoarthritis trials: meta‐epidemiological study. BMJ2010;341:c3515. [DOI: 10.1136/bmj.c3515] ">Nüesch 2010</a>). The greatest number randomised was 54 (although only 38 provided data) (<a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>) so the risk of bias is high for this item. </p> </section> </section> <section id="CD011003-sec2-0010"> <h3 class="title" id="CD011003-sec2-0010">Effects of interventions</h3> <p>See: <a href="./full#CD011003-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD011003-sec3-0026"> <h4 class="title">Efficacy</h4> <p>There was no first or second tier evidence of efficacy. Evidence was downgraded primarily because of the short duration of the studies, small numbers of participants in comparisons, reporting of completer analyses in cross‐over studies, and lack of desirable primary outcomes. </p> <p>Details of data from individual studies are shown in <a href="./appendices#CD011003-sec2-0020">Appendix 5</a>. </p> <section id="CD011003-sec4-0003"> <h5 class="title">Third tier evidence</h5> <p>None of the studies reported our primary outcome of participants with at least 30% or at least 50% reduction in pain intensity. Four studies used a six‐point scale to assess the Patient Global evaluation of Pain Relief (PGPR) (complete, a lot, moderate, slight, none, worse). We considered that PGPR complete or a lot was equivalent to our primary outcome of PGIC very much improved, and PGPR complete, a lot, or moderate was equivalent to PGIC much or very much improved. </p> <p><a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a> reported that PGPR was complete or a lot for 8/19 (ITT 8/26) taking desipramine (1/19 with placebo; ITT 1/26) and at least moderate for 12/19 with desipramine (2/19 with placebo). Participants' weekly rating of pain intensity was significantly lower with desipramine than with placebo by the end of the study. Some pain components were also reduced compared with placebo (steady: 9/19 compared with 1/19; brief: 4/8 compared with 0/8; mechanical allodynia: 7/18 compared with 1/18). </p> <p><a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a> reported similar findings that PGPR was complete or a lot for 4/20 (ITT 4/24) taking desipramine (2/20 with placebo; ITT 2/24) and at least moderate for 11/20 with desipramine (2/20 with placebo). Participants' weekly rating of pain intensity was significantly lower with desipramine than with placebo by the end of the study. Some pain components were also reduced compared with placebo: pain described as "steady, burning pain" was significantly reduced). </p> <p><a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a> found that PGPR was similar for desipramine and amitriptyline (placebo not used): complete or a lot for 15/38 (ITT 15/54) and 18/38 (ITT 18/54) participants respectively, and at least moderate for 23/38 and 28/38 respectively. Participants' weekly rating of pain intensity was not significantly different. </p> <p><a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a> reported that Visual Analogue Scale (VAS) readings fell by 47% with desipramine, compared with 38% and 35% falls with amitriptyline and fluoxetine respectively. PGPR was at least moderate for 12/15 with desipramine, 9/17 with amitriptyline, and 5/15 with fluoxetine (ITT analysis). </p> <p>In <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>, pain was not reported separately but as part of a set of neuropathy symptoms. Both observers and participants reported a significant reduction in symptom scores with desipramine compared to placebo; there was a non‐significant fall in the individual pain item score with desipramine. </p> </section> </section> <section id="CD011003-sec3-0027"> <h4 class="title">Adverse events</h4> <p>Details of adverse events reported in individual studies are in <a href="./appendices#CD011003-sec2-0021">Appendix 6</a>. All studies reported some information about adverse events, but reporting was inconsistent and fragmented. </p> <section id="CD011003-sec4-0004"> <h5 class="title">Participants experiencing any adverse event</h5> <p>One study reported the number of participants who experienced one or more adverse events for all those who were treated (ITT) (<a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>). Two studies reported this number for completers (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>). Two studies reported on mean or median adverse event scores (based on the intensity of the event) for completers only (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). </p> <p><a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a> reported that all completers had experienced at least one adverse event with desipramine (19/19), while 15/19 had done so with placebo. The most common events with desipramine were dry mouth, constipation, dizziness, sedation, micturition difficulty, insomnia, and sweating. The most common with placebo were dry mouth, dizziness, and constipation, but these were experienced at lower levels than with desipramine. </p> <p><a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a> reported that nearly all completers had experienced at least one adverse event with desipramine (18/20), while nearly as many had done so with placebo (15/19). The most common (over 10%) events with desipramine were dry mouth, sedation, insomnia, constipation, orthostatic symptoms, palpitations, and increased sweating. The most common with placebo were dry mouth, sedation, constipation, and insomnia. Insomnia, constipation, and dry mouth were slightly more frequent with desipramine. </p> <p><a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a> reported similar numbers of participants with one or more adverse events with both desipramine (29/54) and amitriptyline (31/54). The most common (over 10%) events with desipramine were dry mouth, tiredness, constipation, insomnia, increased sweating, headache, lightheadedness. Figures were similar for amitriptyline. </p> <p><a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a> reported that completers' scores (presumably means) on a symptom checklist increased by more than 1 (for a range of 0 to 3) for adverse events as follows.<br/> Desipramine and amitriptyline: dry mouth, constipation, bitter taste; fluoxetine: sleepiness and lightheadedness. </p> <p><a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a> reported medians of completers' total scores for 14 side effects, with observers assigning values to each symptom (5‐point scale from 0 to 2.0). For desipramine and clomipramine the medians of the total scores were 4.5 and 4.0 respectively. They reported a median of 0.02 for placebo scores but this must be erroneous. </p> </section> <section id="CD011003-sec4-0005"> <h5 class="title">Participants experiencing any serious adverse event</h5> <p>No serious adverse events were reported during desipramine treatment, though one participant was hospitalised for nausea and weakness with hyponatraemia during fluoxetine treatment (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>). </p> <p>There were no deaths.</p> </section> </section> <section id="CD011003-sec3-0028"> <h4 class="title">Withdrawals</h4> <p>All five studies reported on withdrawals. Details of withdrawals reported in individual studies are in <a href="./appendices#CD011003-sec2-0021">Appendix 6</a>. </p> <section id="CD011003-sec4-0006"> <h5 class="title">Withdrawals due to adverse events</h5> <p>All five studies reported on withdrawals due to adverse events.</p> <p>In four studies (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>) 17/130 participants withdrew during desipramine treatment, 4/76 during placebo treatment (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>), 7/54 during amitriptyline treatment (<a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>), and 3/26 during clomipramine treatment (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). </p> <p>There was a variety of reasons for these withdrawals: three were due to rash, two to fever, two to bundle branch block, five to possible symptoms of low blood pressure, and one each to tiredness, insomnia, palpitations, tremor, jitteriness, chest pain, and "seizure". </p> <p>The four placebo withdrawals were due to combinations of vertigo, nausea, rash, unsteadiness, mental fogginess, and chest pain. All occurred with the 'active' placebo treatment. </p> <p><a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a> reported nine withdrawals but gave reasons for only five of these. There were 2/15 with desipramine and 2/17 with amitriptyline: adverse events were cited for three of these but the drug involved was not specified. There were 5/15 withdrawals with fluoxetine, adverse events being cited for two of these and no reason given for the others. </p> </section> <section id="CD011003-sec4-0007"> <h5 class="title">Withdrawals due to lack of efficacy</h5> <p>There were no withdrawals due to lack of efficacy with desipramine, one with placebo (<a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>), and one with clomipramine (<a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a>). </p> </section> <section id="CD011003-sec4-0008"> <h5 class="title">Withdrawals for other reasons</h5> <p><a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a> reported 2/26 withdrawals for "intercurrent illness", and <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a> reported two "voluntary" withdrawals. </p> <p>As noted above, <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a> gave reasons for only 5/9 withdrawals. Three from the fluoxetine arm remain unexplained, as did one from either the desipramine or amitriptyline arms. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011003-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011003-sec1-0006"></div> <section id="CD011003-sec2-0011"> <h3 class="title" id="CD011003-sec2-0011">Summary of main results</h3> <p>We found five studies enrolling 177 participants with chronic neuropathic pain, 59% of whom had painful diabetic neuropathy and 41% of whom had postherpetic neuralgia. </p> <p>None of the studies reported our primary outcomes of at least 30% or at least 50% pain relief, but three reported outcomes we considered equivalent to our other primary outcomes of PGIC much or very much improved, and PGIC very much improved. No first or second tier evidence was available. No pooling of data was possible, but third tier evidence in individual studies indicated some improvement in pain relief with desipramine compared with placebo, although this was derived mainly from group mean data and completer analyses (see <a href="./appendices#CD011003-sec2-0016">Appendix 1</a>), in small, short duration studies where major bias is possible. Participants taking desipramine experienced more adverse events, and a higher rate of withdrawal due to adverse events, than did participants taking placebo. See <a href="./full#CD011003-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Comparison with alternative treatments indicate more effective and safer medicines are available (<a href="./references#CD011003-bbs2-0031" title="LunnMP , HughesRA , WiffenPJ . Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews2014, Issue 1. [DOI: 10.1002/14651858.CD007115.pub3] ">Lunn 2014</a>; <a href="./references#CD011003-bbs2-0038" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>; <a href="./references#CD011003-bbs2-0050" title="MooreRA , WiffenPJ , DerryS , ToelleT , RiceAS . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD007938.pub3] ">Moore 2014b</a>). </p> </section> <section id="CD011003-sec2-0012"> <h3 class="title" id="CD011003-sec2-0012">Overall completeness and applicability of evidence</h3> <p>Desipramine was tested only in painful diabetic neuropathy and postherpetic neuralgia, so results cannot be reliably extrapolated to other neuropathic conditions. </p> <p>Since desipramine is a TCA, depression among participants may conceivably affect the results. Three studies excluded people with severe depression (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>). One reported on the incidence of depression in participants and its progress during the trial (<a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a>); the small numbers involved do not lend themselves to any conclusion about the effect of depression on pain relief. <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a> do not mention depression. Three studies showed a rapid onset of pain relief (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>), consistent with prompt action on sodium channels, and a different mechanism of action than that of its antidepressant effect. <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a> do not describe the speed of onset; <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a> only tested for two weeks and, while there is evidence of pain relief, changes were not significant. </p> <p>Short‐term studies (less than six weeks) may not accurately predict longer‐term efficacy in chronic conditions: four studies were of six weeks' duration, while one was of only two weeks duration. Furthermore, caution is required in interpreting adverse event data from short duration studies for real world clinical practice, particularly where so few participants have been studied. </p> </section> <section id="CD011003-sec2-0013"> <h3 class="title" id="CD011003-sec2-0013">Quality of the evidence</h3> <p>Reporting quality in the studies was generally poor by current standards. While all the studies were randomised and double‐blind, none provided data that met predefined criteria for first or second tier analysis. All the studies were small (with a maximum of 54 participants in any treatment arm). Four of the five were of short duration (six weeks), used cross‐over design without separate reporting of first period data, and reported only on participants who completed more than one phase of treatment. One was of very short duration (two weeks). </p> <p>Differential rates of adverse events between placebo and treatment arms can suggest unblinding, but in these studies adverse events were assessed inconsistently, making comparisons difficult. None of the studies reported asking participants to guess their allocation at the end of the trial to check for unblinding. The methods used to collect adverse events could usefully include symptom checklists for self‐completion at baseline and at assessment points; these can even be graded for severity. Three studies did this (<a href="./references#CD011003-bbs2-0001" title="Kishore‐KumarR , MaxMB , SchaferSC , GaughanAM , SmollerB , GracelyRH , DubnerR . Desipramine relieves postherpetic neuralgia. Clinical Pharmacology and Therapeutics1990;47(3):305‐12. ">Kishore‐Kumar 1990</a>; <a href="./references#CD011003-bbs2-0002" title="MaxMB , Kishore‐KumarR , SchaferSC , MeisterB , GracelyRH , SmollerB , DubnerR . Efficacy of desipramine in painful diabetic neuropathy: a placebo‐controlled trial. Pain1991;45:3‐9. ">Max 1991</a>; <a href="./references#CD011003-bbs2-0003" title="MaxMB , LynchSA , MuirJ , ShoafSE , SmollerB , DubnerR . Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine1992;326(19):1250‐6. ">Max 1992</a>), giving proportions reporting particular symptoms, but not reporting the time course of adverse events. <a href="./references#CD011003-bbs2-0004" title="RowbothamMC , ReisnerLA , DaviesPS , FieldsHL . Treatment response in antidepressant‐naïve postherpetic neuralgia patients: double‐blind, randomized trial. Journal of Pain2005;6(11):741‐6. ">Rowbotham 2005</a> used a checklist but only reported qualitatively. <a href="./references#CD011003-bbs2-0005" title="SindrupSH , GramLF , SkjoldT , GrodumE , BrøsenK , Beck‐NielsenH . Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double‐blind cross‐over study. British Journal of Clinical Pharmacology1990;30(5):683‐91. ">Sindrup 1990</a> seems to have used a checklist but reported only median scores (and those incorrectly). </p> </section> <section id="CD011003-sec2-0014"> <h3 class="title" id="CD011003-sec2-0014">Potential biases in the review process</h3> <p>The review was restricted to randomised double‐blind studies, thus limiting the potential for bias. Other possible sources of bias that could have affected the review included the following. </p> <p> <ul id="CD011003-lst1-0008"> <li> <p>Duration: NNT estimates of efficacy in chronic pain studies tend to increase (get worse) with increasing duration (<a href="./references#CD011003-bbs2-0040" title="MooreRA , MooreOA , DerryS , PelosoPM , GammaitoniAR , WangH . Responder analysis for pain relief and numbers needed to treat in a meta‐analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases2010;69(2):374‐9. [DOI: 10.1136/ard.2009.107805] ">Moore 2010b</a>). None of the studies lasted more than six weeks, which may lead to an overestimate of efficacy. </p> </li> <li> <p>The degree of exaggeration of treatment effects in cross‐over trials compared to parallel‐group designs, as has been seen in some circumstances (<a href="./references#CD011003-bbs2-0027" title="KhanKS , DayaS , JadadA . The importance of quality of primary studies in producing unbiased systematic reviews. Archives of Internal Medicine1996;156(6):661‐6. ">Khan 1996</a>), is unclear but unlikely to be the source of major bias (<a href="./references#CD011003-bbs2-0017" title="ElbourneDR , AltmanDG , HigginsJP , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. [DOI: 10.1093/ije/31.1.140] ">Elbourne 2002</a>). Withdrawals meant that any results were more likely to be per protocol for completers than for a true ITT analysis. The majority of data in this review were from cross‐over studies. </p> </li> <li> <p>All four cross‐over studies reported results only for those who completed at least two treatment periods, which is likely to overestimate efficacy. Where possible, we have indicated results for an ITT analysis (adding missing participants back into the denominator) for one primary outcome, to give a more conservative estimate. </p> </li> <li> <p>The absence of publication bias (unpublished trials showing no benefit of desipramine over placebo) can never be proven. We carried out a broad search for studies and feel it is unlikely that significant amounts of data remain unknown to us. </p> </li> </ul> </p> </section> <section id="CD011003-sec2-0015"> <h3 class="title" id="CD011003-sec2-0015">Agreements and disagreements with other studies or reviews</h3> <p>This new review does not change the results of the previous Cochrane review (<a href="./references#CD011003-bbs2-0068" title="SaartoT , WiffenPJ . Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2] ">Saarto 2007</a>). </p> <p>Guidelines to treat neuropathic pain in Europe and UK do not specifically recommend use of desipramine (<a href="./references#CD011003-bbs2-0009" title="AttalN , CruccuG , BaronR , HaanpääM , HanssonP , JensenTS , et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x] ">Attal 2010</a>; <a href="./references#CD011003-bbs2-0052" title="NICE clinical guideline 173. Neuropathic pain – pharmacological management. www.nice.org.uk/guidance/CG173 (accessed 24 March 2014)2013:1‐138. ">NICE 2013</a>). In USA, <a href="./references#CD011003-bbs2-0016" title="DworkinRH , O'ConnorAB , AudetteJ , BaronR , GourlayGK , HaanpääML , et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings2010;85(3 Suppl):S3‐14. [DOI: 10.4065/mcp.2009.0649] ">Dworkin 2010</a> recommend desipramine as an alternative to nortriptyline as a first‐line TCA treatment for neuropathic pain. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011003-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/urn:x-wiley:14651858:media:CD011003:CD011003-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_t/tCD011003-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011003-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011003-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/urn:x-wiley:14651858:media:CD011003:CD011003-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_t/tCD011003-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011003-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011003-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/urn:x-wiley:14651858:media:CD011003:CD011003-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_t/tCD011003-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011003-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/media/CDSR/CD011003/image_n/nCD011003-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011003-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Desipramine compared with placebo for painful diabetic neuropathy and postherpetic neuralgia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia) </p> <p><b>Settings:</b> community </p> <p><b>Intervention:</b> Desipramine 12.5 mg to 250 mg daily </p> <p><b>Comparison:</b> Placebo (or active placebo ‐ benztropine) </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Outcome with comparator (placebo)</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Outcome with intervention</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 50% reduction in pain</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 30% reduction in pain</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion below 30/100 mm on VAS</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patient Global Impression of Change very much improved (PGPR "complete" or "a lot")</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>3.8 % and 8.3% (3 events)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>17% and 30%</p> <p>(12 events)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 participants, 2 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 2 studies with short duration, cross‐over design, different painful neuropathy condition </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patient Global Impression of Change much or very much improved (PGPR "complete", "a lot", or "moderate") </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>7.7% and 8.3%</p> <p>(4 events)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>46% in both studies</p> <p>(23 events)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 participants, 2 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 2 studies with short duration, cross‐over design, different painful neuropathy condition </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse event withdrawals</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0% to 12%</p> <p>(4 events)</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0% to 19%</p> <p>(10 events)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not calculated</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 participants, 3 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 3 studies with short duration, cross‐over design</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177 participants, 5 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 5 studies of short duration (placebo‐ and active‐controlled)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Death</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177 participants, 5 studies</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n/a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small numbers of participants in 5 studies of short duration (placebo‐ and active‐controlled)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI: confidence interval; PGPR: Patient global evaluation of pain relief; RR: risk ratio; VAS: visual analogue scale; n/a: not applicable </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011003.pub2/full#CD011003-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011003.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011003-note-1206">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011003-note-1205">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD011003-note-1204">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011003\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011003\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011003\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011003\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011003\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011003.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011003.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011003.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011003.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011003.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728719224"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011003.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728719232"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011003.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ecb567c58f56f',t:'MTc0MDcyODcxOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 